Literature DB >> 4042529

Pharmacokinetics of high-dose pentobarbital in severe head trauma.

C D Bayliff, M L Schwartz, B G Hardy.   

Abstract

High-dose pentobarbital infusion has been advocated as an effective adjunct in controlling persistent intracranial hypertension after severe head trauma in patients refractory to conventional therapy. Pentobarbital disposition was assessed in 10 adults with severe nonpenetrating head injury after an intravenous loading dose of sodium pentobarbital, 10 mg/kg, infused over 1 hour, followed by a continuous infusion at 0.5 to 3.0 mg/kg/hr provided the cerebral perfusion pressure remained greater than 50 torr. Pharmacokinetic parameters of volume of distribution at steady state (Vss), total body clearance (CL), and t1/2 for the patients with trauma were statistically compared with similar estimates reported for seven adult subjects without head injury. On discontinuation of the pentobarbital infusion, serum concentrations in the patients followed a monoexponential decline with a mean (+/- SD) t1/2 and Vss that were significantly less than values reported for the control subjects (15.6 +/- 3.9 vs. 22.3 +/- 4.0 hours and 44.0 +/- 11.7 vs. 63.4 +/- 15.2 L, respectively). However, there was no significant difference between the mean pentobarbital CL of the patients (2.0 +/- 0.7 L/hr) and the subjects (2.0 +/- 0.4 L/hr). To our knowledge this is the first report on the disposition, elimination, and intrasubject variability of high-dose pentobarbital infusion in adult patients with head trauma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042529     DOI: 10.1038/clpt.1985.204

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  A randomized trial for the treatment of refractory status epilepticus.

Authors:  Andrea O Rossetti; Tracey A Milligan; Serge Vulliémoz; Costas Michaelides; Manuel Bertschi; Jong Woo Lee
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 3.  Barbiturates in severe head injuries?

Authors:  D Moskopp; F Ries; H Wassmann; J Nadstawek
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

Review 4.  Diagnostic Accuracy of Transcranial Doppler for Brain Death Confirmation: Systematic Review and Meta-Analysis.

Authors:  J J Chang; G Tsivgoulis; A H Katsanos; M D Malkoff; A V Alexandrov
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-29       Impact factor: 3.825

5.  Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery.

Authors:  Athena F Zuppa; Susan C Nicolson; Jeffrey S Barrett; Marc R Gastonguay
Journal:  J Pediatr       Date:  2011-06-12       Impact factor: 4.406

Review 6.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

7.  Treatment options in the management of status epilepticus.

Authors:  Andrea O Rossetti
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

8.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 9.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 10.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.